litlas
Log inCreate account

Lars Bullinger

Active 1997–2026

219
Papers
39,209
Citations
96
h-index
204
i10-index

Citations

Citations per year for Lars Bullinger1943: 1 citations1984: 2 citations1991: 1 citations1998: 2 citations1999: 6 citations2000: 8 citations2001: 16 citations2002: 53 citations2003: 58 citations2004: 60 citations2005: 78 citations2006: 117 citations2007: 115 citations2008: 175 citations2009: 179 citations2010: 225 citations2011: 275 citations2012: 302 citations2013: 335 citations2014: 362 citations2015: 340 citations2016: 382 citations2017: 430 citations2018: 405 citations2019: 1,542 citations2020: 1,669 citations2021: 1,570 citations2022: 1,296 citations2023: 1,090 citations2024: 1,540 citations2025: 780 citations2026: 29 citations1944–1983: no citations, so these years are not shown1985–1990: no citations, so these years are not shown1992–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,624 citing papers, 26.9% of this breakdownGermany: 1,763 citing papers, 10.2% of this breakdownChina: 1,662 citing papers, 9.7% of this breakdownUnited Kingdom: 1,117 citing papers, 6.5% of this breakdownItaly: 879 citing papers, 5.1% of this breakdownFrance: 672 citing papers, 3.9% of this breakdownSpain: 578 citing papers, 3.4% of this breakdownCanada: 539 citing papers, 3.1% of this breakdownNetherlands: 526 citing papers, 3% of this breakdownAustralia: 423 citing papers, 2.5% of this breakdownJapan: 413 citing papers, 2.4% of this breakdownSwitzerland: 392 citing papers, 2.3% of this breakdown
0%26.9%Other 21%

Institutions

Fields

  • Medicine61.7%
  • Biochemistry, Genetics and Molecular Biology32.8%
  • Immunology and Microbiology3.2%
  • Computer Science0.6%
  • Neuroscience0.3%
  • Chemistry0.3%
  • Other1.1%

Topics

  • Acute Myeloid Leukemia Research12.8%
  • Epigenetics and DNA Methylation4.2%
  • Chronic Lymphocytic Leukemia Research4%
  • Protein Degradation and Inhibitors3.6%
  • Cancer Genomics and Diagnostics3.4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3%
  • Other69%

Coauthors

All papers

Open in search
  1. Genomic Classification and Prognosis in Acute Myeloid Leukemia

    Authors: Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I. Gaidzik, Peter Paschka, Nicola D. Roberts, Nicola Potter, Michael Heuser, Felicitas Thol, Niccolò Bolli, Gunes Gundem, Peter Van Loo, Iñigo Martincorena, Peter Ganly, Laura Mudie, Stuart McLaren, Sarah O’Meara, Keiran Raine, David Jones, Jon W. Teague, Adam P. Butler, Mel Greaves, Arnold Ganser, Konstanze Döhner, Richard F. Schlenk, Hartmut Döhner, Peter J. Campbell - New England Journal of Medicine 2016 cited by 4,363

  2. Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS

    Authors: Jan Krönke, Emma C. Fink, Paul W. Hollenbach, Kyle J. MacBeth, Slater N. Hurst, Namrata D. Udeshi, Philip P. Chamberlain, D.R. Mani, Hon Wah Man, Anita K. Gandhi, Tanya Svinkina, Rebekka K. Schneider, Marie McConkey, Marcus Järås, Elizabeth A. Griffiths, Meir Wetzler, Lars Bullinger, Brian E. Cathers, Steven A. Carr, Rajesh Chopra, Benjamin L. Ebert - Nature 2015 cited by 848

  3. A 17-gene stemness score for rapid determination of risk in acute leukaemia

    Authors: Stanley Ng, Amanda Mitchell, Theodore A. Kennedy, Weihsu C. Chen, Jessica McLeod, Narmin Ibrahimova, Andrea Arruda, Andreea C. Popescu, Vikas Gupta, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Lars Bullinger, Tobias Herold, Dennis Görlich, Thomas Büchner, Wolfgang Hiddemann, Wolfgang E. Berdel, Bernhard Wörmann, Meyling Cheok, Claude Preudhomme, Hervé Dombret, Klaus H. Metzeler, Christian Buske, Bob Löwenberg, Peter J.M. Valk, Peter W. Zandstra, Mark D. Minden, John E. Dick, Jean Wang - Nature 2016 cited by 939

  4. The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

    Authors: Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni, Olaf Penack, Veit Bücklein, Liv Jentzsch, Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L. Locke, Michael von Bergwelt‐Baildon, Andréas Mackensen, Wolfgang Bethge, Pere Barba, Michael D. Jain, Marion Subklewe - Journal for ImmunoTherapy of Cancer 2022 cited by 191

  5. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

    Authors: Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim P. Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf‐Dieter Kortmann, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Oliver Schnell, Oliver Bähr, Martin Uhl, Clemens Seidel, Ghazaleh Tabatabai, Thomas E. Kowalski, Florian Ringel, Friederike Schmidt‐Graf, Bogdana Suchorska, Stefanie Brehmer, Astrid Weyerbrock, Miriam Renovanz, Lars Bullinger, Norbert Galldiks, Peter Vajkoczy, Martin Misch, Hartmut Vatter, Moritz Stuplich, Niklas Schäfer, Sied Kebir, Johannes Weller, Christina Schaub, Walter Stummer, Jörg‐Christian Tonn, Matthias Simon, Vera C. Keil, Michael Nelles, Horst Urbach, Martin Coenen, Wolfgang Wick, Michael Weller, Rolf Fimmers, Matthias Schmid, Elke Hattingen, Torsten Pietsch, Christoph Coch, Martin Glas - The Lancet 2019 cited by 576

  6. Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

    Authors: Hartmut Döhner, Stephan Stilgenbauer, Axel Benner, Elke Leupolt, Alexander Kröber, Lars Bullinger, Konstanze Döhner, Martin Bentz, Peter Lichter - New England Journal of Medicine 2000 cited by 3,296

  7. Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia

    Authors: Hannah J. Uckelmann, Stephanie M. Kim, Eric Wong, Charlie Hatton, Hugh Giovinazzo, Jayant Y. Gadrey, Andrei V. Krivtsov, Frank G. Rücker, Konstanze Döhner, Gerard M. McGeehan, Ross L. Levine, Lars Bullinger, George S. Vassiliou, Scott A. Armstrong - Science 2020 cited by 271

  8. Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia

    Authors: Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer - Haematologica 2019 cited by 203

  9. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

    Authors: Simon Raffel, Mattia Falcone, Niclas Kneisel, Jenny Hansson, Wei Wang, Christoph Lutz, Lars Bullinger, Gernot Poschet, Yannic Nonnenmacher, Andrea Barnert, Carsten Bahr, Petra Zeisberger, Adriana Przybylla, Markus Sohn, Martje Tönjes, Ayelet Erez, Lital N. Adler, Patrizia Jensen, Claudia Scholl, Stefan Fröhling, Sibylle Cocciardi, Patrick Wuchter, Christian Thiede, Anne Flörcken, Jörg Westermann, Gerhard Ehninger, Peter Lichter, Karsten Hiller, Rüdiger Hell, Carl Herrmann, Anthony D. Ho, Jeroen Krijgsveld, Bernhard Radlwimmer, Andreas Trumpp - Nature 2017 cited by 353

  10. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations

    Authors: Tobias Rausch, David Jones, Marc Zapatka, Adrian M. Stütz, Thomas Zichner, Joachim Weischenfeldt, Natalie Jäger, Marc Remke, David Shih, Paul A. Northcott, Elke Pfaff, Jelena Tica, Qi Wang, Luca Massimi, Hendrik Witt, Sebastian Bender, Sabrina Pleier, Huriye Cin, Cynthia Hawkins, Christian Beck, Andreas von Deimling, Volkmar Hans, Benedikt Brors, Roland Eils, Wolfram Scheurlen, Jonathon Blake, Vladimı́r Beneš, Andreas E. Kulozik, Olaf Witt, Dianna C. Martin, Cindy Zhang, Rinnat M. Porat, Diana M. Merino, Jonathan D. Wasserman, Nada Jabado, Adam M. Fontebasso, Lars Bullinger, Frank G. Rücker, Konstanze Döhner, Hartmut Döhner, Jan Köster, Jan J. Molenaar, Rogier Versteeg, Marcel Kool, Uri Tabori, David Malkin, Andrey Korshunov, Michael D. Taylor, Peter Lichter, Stefan M. Pfister, Jan O. Korbel - Cell 2012 cited by 878

  11. Unified classification and risk-stratification in Acute Myeloid Leukemia

    Authors: Yanis Tazi, Juan E. Arango‐Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie Freeman, Yoann Pradat, Sean Johnson, Robert K. Hills, Richard Dillon, Max F. Levine, Daniel Leongamornlert, Adam P. Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver G. Ottmann, Richard Adams, Hartmut Döhner, Peter J. Campbell, Alan K. Burnett, Michael Dennis, Nigel H. Russell, Sean M. Devlin, Brian J.P. Huntly, Elli Papaemmanuil - Nature Communications 2022 cited by 175

  12. MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L

    Authors: Kathrin M. Bernt, Nan Zhu, Amit Sinha, Sridhar Vempati, Joerg Faber, Andrei V. Krivtsov, Zhaohui Feng, Natalie Punt, Amanda J. Daigle, Lars Bullinger, Roy M. Pollock, Victoria M. Richon, Andrew L. Kung, Scott A. Armstrong - Cancer Cell 2011 cited by 893

  13. SEURAT: Visual analytics for the integrated analysis of microarray data

    Authors: Alexander Gribov, Martin Sill, Sonja C Lück, Frank G. Rücker, Konstanze Döhner, Lars Bullinger, Axel Benner, Antony Unwin - BMC Medical Genomics 2010 cited by 257

  14. Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke

    Authors: Christopher Maximilian Arends, Thomas Liman, Paulina M. Strzelecka, Anna Kufner, Pelle Löwe, Shufan Huo, Catarina M. Stein, Sophie K. Piper, Marlon Tilgner, Pia S. Sperber, Savvina Dimitriou, Peter U. Heuschmann, Raphael Hablesreiter, Christoph Harms, Lars Bullinger, Joachim E. Weber, Matthias Endres, Frédérik Damm - Blood 2022 cited by 94

  15. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

    Authors: Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Sabine Käyser, Veronica Teleanu, H. Kett, Marianne Habdank, Carla-Maria Kugler, Karlheinz Holzmann, Verena I. Gaidzik, Peter Paschka, Gerhard Held, Marie von Lilienfeld‐Toal, Michael Lübbert, Stefan Fröhling, Thorsten Zenz, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Peter Lichter, Konstanze Döhner, Hartmut Döhner - Blood 2011 cited by 678

  16. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

    Authors: Felicitas Thol, Razif Gabdoulline, Alessandro Liebich, Piroska Klement, Johannes Schiller, Christian Kandziora, Lothar Hambach, Michael Stadler, Christian Koenecke, Madita Flintrop, Mira Pankratz, Martin Wichmann, Blerina Neziri, Konstantin Büttner, Bennet Heida, Sabrina Klesse, Anuhar Chaturvedi, Arnold Kloos, Gudrun Göhring, Brigitte Schlegelberger, Verena I. Gaidzik, Lars Bullinger, Walter Fiedler, Albert Heim, Iyas Hamwi, Matthias Eder, Jürgen Krauter, Richard F. Schlenk, Peter Paschka, Konstanze Döhner, Hartmut Döhner, Arnold Ganser, Michael Heuser - Blood 2018 cited by 301

  17. Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

    Authors: Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla Reid, Rawan Faramand, Marco L. Davila, Karnav Modi, Erin Dean, Christina A. Bachmeier, Michael von Bergwelt‐Baildon, Frederick L. Locke, Wolfgang Bethge, Lars Bullinger, Andréas Mackensen, Pere Barba, Michael D. Jain, Marion Subklewe - Science Advances 2023 cited by 59

  18. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways

    Authors: Lars Bullinger, Konstanze Döhner, Hartmut Döhner - Journal of Clinical Oncology 2017 cited by 585

  19. Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin

    Authors: Laura K. Schmalbrock, Anna Dolnik, Sibylle Cocciardi, Eric Sträng, Frauke Theis, Nikolaus Jahn, Ekaterina Panina, Tamara J. Blätte, Julia Herzig, Sabrina Skambraks, Frank G. Rücker, Verena I. Gaidzik, Peter Paschka, Walter Fiedler, Helmut R. Salih, Gerald Wulf, Thomas Schroeder, Michael Lübbert, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Richard A. Larson, Arnold Ganser, Hendrik G. Stunnenberg, Saverio Minucci, Richard M. Stone, Clara D. Bloomfield, Hartmut Döhner, Konstanze Döhner, Lars Bullinger - Blood 2021 cited by 158

  20. Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia

    Authors: Claudia Bruedigam, Amy H. Porter, Axia Song, Gerjanne Vroeg in de Wei, Thomas Stoll, Jasmin Straube, Leanne Cooper, Guidan Cheng, Vivian Francília Silva Kahl, Alexander P. Sobinoff, Victoria Ling, Billy Michael Chelliah Jebaraj, Yashaswini Janardhanan, Rohit Haldar, Laura J. Bray, Lars Bullinger, Florian H. Heidel, Glen Kennedy, Michelle M. Hill, Hilda A. Pickett, Omar Abdel‐Wahab, Günter Härtel, Steven Lane - Nature Cancer 2023 cited by 77

  21. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms

    Authors: Ashok Kumar Jayavelu, Tina M. Schnöder, Florian Perner, Carolin Herzog, Arno Meiler, Gurumoorthy Krishnamoorthy, Nicolas Huber, Juliane Mohr, Bärbel Edelmann-Stephan, Rebecca Austin, Sabine Brandt, Francesca Palandri, Nicolas W.J. Schröder, Berend Isermann, Frank Edlich, Amit Sinha, Martin Ungelenk, Christian A. Hübner, Robert Zeiser, Susann Rahmig, Claudia Waskow, Iain Coldham, Thomas Ernst, Andreas Hochhaus, Stefanie Jilg, Philipp J. Jost, Ann Mullally, Lars Bullinger, Peter R. Mertens, Steven Lane, Matthias Mann, Florian H. Heidel - Nature 2020 cited by 156

  22. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    Authors: Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung, Mathijs A. Sanders, Todd Hricik, Franck Rapaport, Jay Patel, Richard Dillon, Priyanka Vijay, Anna Brown, Alexander E. Perl, Joy Cannon, Lars Bullinger, Selina M. Luger, Michael W. Becker, Ian D. Lewis, Luen Bik To, Ruud Delwel, Bob Löwenberg, Hartmut Döhner, Konstanze Döhner, Mónica L. Guzmán, Duane C. Hassane, Gail J. Roboz, David Grimwade, Peter J.M. Valk, Richard J. D’Andrea, Martin Carroll, Christopher Y. Park, Donna Neuberg, Ross L. Levine, Ari Melnick, Christopher E. Mason - Nature Medicine 2016 cited by 401

  23. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis

    Authors: Christopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, Willy Chan, Marten Jäger, Kenichi Yoshida, Ricarda Seemann, Daniel Noerenberg, Nils Waldhueter, Helga Fleischer-Notter, Friederike Christen, Clemens A. Schmitt, Bernd Dörken, Uwe Pelzer, Marianne Sinn, Tomasz Żemojtel, Seishi Ogawa, Sven Märdian, Adrian Schreiber, Annegret Kunitz, Ulrike Krüger, Lars Bullinger, Elena Mylonas, Mareike Frick, Frédérik Damm - Leukemia 2018 cited by 191

  24. Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

    Authors: Michael Heuser, Bennet Heida, Konstantin Büttner, Clara Wienecke, Katrin Teich, Carolin Funke, Maximilian Brandes, Piroska Klement, Alessandro Liebich, Martin Wichmann, Blerina Neziri, Anuhar Chaturvedi, Arnold Kloos, Konstantinos Mintzas, Verena I. Gaidzik, Peter Paschka, Lars Bullinger, Walter Fiedler, Albert Heim, Wolfram Puppe, Jürgen Krauter, Konstanze Döhner, Hartmut Döhner, Arnold Ganser, Michael Stadler, Lothar Hambach, Razif Gabdoulline, Felicitas Thol - Blood Advances 2021 cited by 119